Victory Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.6K | Sell |
11,004
-5
| -0% | -$7 | ﹤0.01% | 2456 |
|
|
2025
Q1 | $16.8K | Buy |
+11,009
| New | +$16.8K | ﹤0.01% | 2436 |
|
|
2022
Q1 | – | Sell |
-22,650
| Closed | -$329K | – | 2724 |
|
|
2021
Q4 | $329K | Sell |
22,650
-11,456
| -34% | -$166K | ﹤0.01% | 2350 |
|
|
2021
Q3 | $614K | Buy |
34,106
+16,282
| +91% | +$293K | ﹤0.01% | 2070 |
|
|
2021
Q2 | $313K | Buy |
17,824
+9,746
| +121% | +$171K | ﹤0.01% | 2398 |
|
|
2021
Q1 | $204K | Buy |
+8,078
| New | +$204K | ﹤0.01% | 2520 |
|
|
2020
Q2 | – | Sell |
-12,662
| Closed | -$14K | – | 2508 |
|
|
2020
Q1 | $14K | Buy |
+12,662
| New | +$14K | ﹤0.01% | 3207 |
|
|
2019
Q4 | – | Sell |
-6,910
| Closed | -$7K | – | 2633 |
|
|
2019
Q3 | $7K | Buy |
+6,910
| New | +$7K | ﹤0.01% | 3360 |
|
|
2019
Q2 | – | Sell |
-102,251
| Closed | -$612K | – | 1822 |
|
|
2019
Q1 | $612K | Buy |
102,251
+29,970
| +41% | +$179K | ﹤0.01% | 1303 |
|
|
2018
Q4 | $534K | Sell |
72,281
-1,350
| -2% | -$9.97K | ﹤0.01% | 1346 |
|
|
2018
Q3 | $1.07M | Sell |
73,631
-3,740
| -5% | -$54.3K | ﹤0.01% | 1262 |
|
|
2018
Q2 | $1.55M | Sell |
77,371
-4,120
| -5% | -$82.3K | ﹤0.01% | 1134 |
|
|
2018
Q1 | $1.43M | Buy |
81,491
+7,990
| +11% | +$140K | ﹤0.01% | 1159 |
|
|
2017
Q4 | $1.81M | Buy |
73,501
+14,290
| +24% | +$352K | ﹤0.01% | 1069 |
|
|
2017
Q3 | $1.53M | Buy |
59,211
+18,190
| +44% | +$469K | ﹤0.01% | 1095 |
|
|
2017
Q2 | $1.11M | Sell |
41,021
-440
| -1% | -$11.9K | ﹤0.01% | 1155 |
|
|
2017
Q1 | $1.24M | Sell |
41,461
-14,699
| -26% | -$438K | ﹤0.01% | 1090 |
|
|
2016
Q4 | $1.52M | Buy |
+56,160
| New | +$1.52M | ﹤0.01% | 980 |
|